Biotech
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 05/14/15 -- Medivation, Inc. (NASDAQ: MDVN) today announced that the following abstract will be presented during an oral presentation at the 2015 American Societ ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 05/14/15 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD)Highlights:Agreement reached with Ridgeback Capital Investments, a US-based specialist healthcare investor, ...
MENLO PARK, CA: Early Results Published in 2015 American Society of Clinical Oncology (ASCO) Annual Meeting Program ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/13/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that new clinical data from its ongoing Phase 2 clinical trial evaluating evofos ...
LAVAL, QUEBEC: - Product platform expected to generate additional plasma-derived orphan drugs in 2015 - 2 PBI-4050 Phase II clinical trials expected to produce efficacy data in patients during 2015 - Expansion of cl ...
SEATTLE, WA: Achieves Total Revenue for Q1 2015 of $1.9 Million; Conference Call to Be Held Today at 4:30 pm Eastern Time ...
NEEDHAM, MA: A Plenary Session at the 2015 Next Generation Dx Summit in Washington, DC Will Connect Diagnostics Professionals From Across the Industry for Guidance on Two Significant Changes in IVD Approval and Re ...
LAVAL, QUEBEC: - Net loss of $20.4M after expensing $9.9M of R&D and $9.5M of non-cash, accounting adjustments - PBI-4050 cleared by Health Canada to commence clinical trials in both metabolic syndrome and resul ...
NORWOOD, MA: First Quarter Marked by Significant Progress on Operational, Clinical and Regulatory Milestones Company Expects to Commence Phase 2 Clinical Studies of Resunab in Scleroderma in 2Q 2015 and Cystic Fib ...
BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 05/13/15 -- Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, der ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 05/12/15 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy co ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/12/15 -- InMed Pharmaceuticals Inc. ("InMed" or the "Company") (CSE: IN)(OTCQB: IMLFF), announced today that it has filed a pro ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 05/12/15 -- Media are invited to attend the free Alberta Innovates Bio Solutions Impact Innovation 2015 event or watch the livestream. Hosted by Jay Ingram, pop ...
SOUTH SAN FRANCISCO, CA: Marks Second FDA Fast Track Designation for Evofosfamide, an Investigational Compound Currently in Phase 3 Clinical Trials ...
FOSTER CITY, CA: ZADAXIN(R) Leads Continued Growth of Core Business in 2015 ...
NEW YORK, NY: Research Previously Published in Proceedings of the National Academy of Sciences ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/11/15 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX: ATTBF)(CSE: ATT), a specialty biotechnology company wi ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 05/11/15 -- (NASDAQ: ATOS) announced today that it will issue financial results and corporate developments for the First Quarter ended March 31, 2015, following the m ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 05/11/15 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") announces a collaboration with NEC Corporation and Yamaguch ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/11/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present ...
